EUVIMEDEUVIMED entdecken
Crossref

Limonin ameliorates hyperuricemia-induced cognitive impairment through modulation of microglial HIF-1α-driven neuroinflammation

Jie Chen, Dexian Li, Xiaohu Chen, Qiuxing He, Anna Zuo, Baizhao Peng, Ying Yang, Chuanghai Wu, Qinghong Chen, Zihao Jiang, Ziwei Li, Wen Fang und 5 weitere

International Immunopharmacology · 2026-11 · 189 · 117410

DOI: 10.1016/j.intimp.2026.117410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-11. Verfasst von Jie Chen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; School of Chinese Medicine, Southern Medical University, Guangzhou…. Hauptthemen laut MEDLINE: Microglia, Hyperuricemia, Hypoxia-Inducible Factor 1, alpha Subunit, Cognitive Dysfunction. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Program key projects, National Natural Science Foundation of China-Guangdong Joint Fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hyperuricemia (HUA), a highly prevalent metabolic disorder, is increasingly linked to cognitive impairment. Limonin (LIM), a natural compound with anti-inflammatory and neuroprotective properties, has the therapeutic benefits, but its underlying mechanisms remain unclear. PURPOSE: This study aimed to investigate the therapeutic effect and mechanism of LIM on HUA-induced cognitive impairment. METHODS: A rat model of HUA-induced cognitive impairment was established using urate oxidase gene knockout (UOX-/-) rat. Uric acid (UA) levels of serum and cerebrospinal fluid (CSF) were measured to confirm hyperuricemia. Cognitive function was assessed using morris water maze test, while neuronal morphology and synaptic integrity were evaluated via Nissl staining and synaptic plasticity biomarkers. Microglial activation and polarization were examined through double immunofluorescence staining of CD86/IBA1 and ARG1/IBA1, inflammatory and oxidative stress markers were quantified using ELISA, qRT-PCR and Western blot. In vitro, BV2 microglial cells were stimulated with UA to model activation and inflammatory responses. HT22 neuronal cells were co-cultured using conditioned medium to assess apoptosis via TUNEL assay and expression of apoptosis-related biomarkers. RNA sequencing was performed to identify key signaling pathways modulated by LIM, and the findings were validated through targeted gene overexpression or inhibition experiments. RESULTS: The UOX-/- rat model successfully recapitulated HUA-induced cognitive impairment, as evidenced by elevated UA levels, alongside significant cognitive deficits. LIM treatment ameliorated these cognitive impairments, attenuated neuropathological alterations, modulated microglial M1/M2 polarization, and reduced neuroinflammation and oxidative damage. In vitro, LIM suppressed UA-induced microglial activation and inflammatory response, while also rescuing neuronal apoptosis in HT22 cells. RNA sequencing revealed involvement of the HIF-1 pathway. HIF-1α inhibitor YC-1 enhanced LIM's effects, whereas HIF-1α activator DMOG reversed them, suggesting that the modulation of the HIF-1α/iNOS pathway contributes to redox homeostasis and neuroinflammation. CONCLUSION: LIM ameliorates HUA-induced cognitive impairment by suppressing microglial activation and neuroinflammation, which is associated with the inhibition of the HIF-1α/iNOS signaling pathway, underscoring its therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaHyperuricemiaHypoxia-Inducible Factor 1, alpha SubunitCognitive DysfunctionLimoninsNeuroinflammatory DiseasesNeuroprotective AgentsAnti-Inflammatory AgentsAnimalsRatsMaleDisease Models, AnimalRats, Sprague-DawleyCell LineSignal Transduction

Stichwörter der Autor:innen

Cognitive impairmentHIF-1αHyperuricemiaLimoninNeuroinflammation

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitlimoninLimoninsNeuroprotective AgentsHif1a protein, ratAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; School of Chinese Medicine, Southern Medical University, Guangzhou, 510515, China; Engineering Research Center of Innovative Traditional…
  • Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; School of Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • School of Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
  • School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, 999077, China.
  • School of Chinese Medicine, Southern Medical University, Guangzhou, 510515, China. Electronic address: sunxiaomin198001@163.com.
  • Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China. Electronic address: zlecho@163.com.

Förderung

  • Guangzhou Municipal Science and Technology Program key projects
  • National Natural Science Foundation of China-Guangdong Joint Fund
  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • Natural Science Foundation of Guangdong Province
  • Guangzhou Municipal Science and Technology Project
  • China Postdoctoral Science Foundation

Zitieren

APA

Chen, J., Li, D., Chen, X., He, Q., Zuo, A., Peng, B., Yang, Y., Wu, C., Chen, Q., Jiang, Z., Li, Z., Fang, W., Lin, J., Kwan, H. Y., Sun, X., Zhou, L., & Zhao, X. (2026). Limonin ameliorates hyperuricemia-induced cognitive impairment through modulation of microglial HIF-1α-driven neuroinflammation. International Immunopharmacology, 189, 117410. https://doi.org/10.1016/j.intimp.2026.117410

Vancouver

Chen J, Li D, Chen X, He Q, Zuo A, Peng B, et al. Limonin ameliorates hyperuricemia-induced cognitive impairment through modulation of microglial HIF-1α-driven neuroinflammation. International Immunopharmacology. 2026;189:117410. doi:10.1016/j.intimp.2026.117410

BibTeX
@article{Chen2026,
  author = {Chen, Jie and Li, Dexian and Chen, Xiaohu and He, Qiuxing and Zuo, Anna and Peng, Baizhao and Yang, Ying and Wu, Chuanghai and Chen, Qinghong and Jiang, Zihao and Li, Ziwei and Fang, Wen and Lin, Jingxin and Kwan, Hiu Yee and Sun, Xiaomin and Zhou, Lin and Zhao, Xiaoshan},
  title = {Limonin ameliorates hyperuricemia-induced cognitive impairment through modulation of microglial HIF-1α-driven neuroinflammation},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {189},
  pages = {117410},
  doi = {10.1016/j.intimp.2026.117410}
}
Kostenlos starten →